Inventor · disambiguated record
Christine Favre
Also filed as: FAVRE CHRISTINE
6 granted patents·4 pending applications·39 citations·filing 2005–2022
80Inventor score
Files withFAVRE CHRISTINE3IPSEN BIOPHARM LTD3SOD CONSEILS RECH APPLIC2AUGUET MICHEL1IPSEN PHARMA SAS1
Top patents by PatentIndex Score
10 records- 0187US8273359B2Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agentFAVRE CHRISTINE·Filed 2007·Granted Sep 25, 2012·14 cites·16 claims
- 0286US8921322B2Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virusFAVRE CHRISTINE·Filed 2007·Granted Dec 30, 2014·12 cites·15 claims
- 0381US8784841B2Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathyFAVRE CHRISTINE·Filed 2009·Granted Jul 22, 2014·7 cites·13 claims
- 0477US9080220B2Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivativeAUGUET MICHEL·Filed 2007·Granted Jul 14, 2015·6 cites·12 claims
- 0555US11975055B2Suppression of bone cancer-induced allodyniaIPSEN BIOPHARM LTD·Filed 2019·Granted May 7, 2024·0 cites·18 claims
- 0654US9259458B2Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathyIPSEN PHARMA SAS·Filed 2014·Granted Feb 16, 2016·0 cites·14 claims
- 0750US2009270400A1Painkilling association comprising a dihydroimidazopyrazine derivativeSOD CONSEILS RECH APPLIC·Filed 2005·Application pending·0 cites
- 0850US2009270401A1Use of a dihydroimidazopyrazoine derivative for treating or preventing painSOD CONSEILS RECH APPLIC·Filed 2005·Application pending·0 cites
- 0950US2025195626A1Treatment of pain & inflammatory disordersIPSEN BIOPHARM LTD·Filed 2022·Application pending·0 cites
- 1047US2025066755A1Catalytically inactive clostridial neurotoxins for the treatment of pain & inflammatory disordersIPSEN BIOPHARM LTD·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →